![]() | |
Agency overview | |
---|---|
Formed | 1928[1] |
Preceding agency |
|
Headquarters | Hamilton, Montana |
Employees | 400[1] |
Parent agency | National Institute of Allergy and Infectious Disease, National Institutes of Health, United States Department of Health & Human Services |
Website | [1] |
Rocky Mountain Laboratories (RML) is part of the NIH Intramural Research Program and is located in Hamilton, Montana. Operated by the National Institute of Allergy and Infectious Diseases, RML conducts research on maximum containment pathogens such as Ebola as well as research on prions and intracellular pathogens such as Coxiella burnetii and Francisella tularensis.[2][3][4] RML operates one of the few Biosafety level 4 laboratories in the United States, as well as Biosafety level 3 and ABSL3/4 laboratories.[5]
In February 2020, electron microscope images of SARS-CoV-2 were collected at RML.[6]